B+L/Novaliq Hope Miebo Can Stand Out In Crowded Dry Eye Field

Big Week For Bausch As Court Ruling Could Benefit Planned Spinoff

The companies got US FDA approval for the drug, which they said is the only approved medicine that targets tear evaporation rather than tear production, though its mechanism is not fully understood.

Bausch + Lomb and Novaliq announced the approval of Miebo in dry eye disease • Source: Shutterstock

More from New Products

More from Scrip